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Abstract
The possibility of the agent causing bovine spongiform encephalopathy (BSE) infecting small ruminants is of serious
concern for human health. Among scrapie cases, the CH1641 source in particular appears to have certain biochemical
properties similar to the BSE strain. In France, several natural scrapie cases were identified as ‘‘CH1641-like’’ natural scrapie
isolates in sheep and goats. The Tg(OvPrP4) mouse line expressing the ovine prion protein is a sensitive model for studying
and identifying strains of agents responsible for scrapie and BSE. This model is also very useful when studying specific
scrapie source CH1641, known to be not transmissible to wild-type mice despite the similarity of some of its biochemical
properties to those of the BSE strain. As it is important to be able to fully distinguish CH1641 from BSE, we herein report the
histopathological data from CH1641 scrapie transmission experiments compared to specific cases of ‘‘CH1641-like’’ natural
scrapie isolates in sheep, murine scrapie strains and BSE. In addition to the conventional vacuolar lesion profile approach
and PrP
d brain mappings, an innovative differential PET-blot analysis was introduced to classify the different strains of agent
and revealed the first direct concordance between ways of grouping strains on the basis of PrP
d biochemical characteristics.
Citation: Bencsik A, Baron T (2011) Histopathological Studies of ‘‘CH1641-Like’’ Scrapie Sources Versus Classical Scrapie and BSE Transmitted to Ovine Transgenic
Mice (TgOvPrP4). PLoS ONE 6(7): e22105. doi:10.1371/journal.pone.0022105
Editor: Andrew Francis Hill, University of Melbourne, Australia
Received January 31, 2011; Accepted June 17, 2011; Published July 13, 2011
Copyright:  2011 Bencsik, Baron. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was partly supported by grants from the Neuroprion European Network of Excellence (FOOD-CT-2004-506579 EUROSTRAINS project) and the
‘‘Infections a ` prions’’ Scientific Interest Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: anna.bencsik@anses.fr
Introduction
Transmissible spongiform encephalopathies (TSEs) are a group
of fatal neurodegenerative disorders that include Creutzfeldt-Jakob
disease in humans, bovine spongiform encephalopathy (BSE) in
cattle, scrapie in sheep and goats and chronic wasting disease in
mule deer. The neuropathological changes typical of TSEs are
vacuolar damage, neuron loss, astrogliosis and abnormal deposi-
tion of the disease-specific form of the normal cellular prion
protein (PrP
c). As the disease progresses, it is admitted that PrP
c is
converted into an abnormal protease-resistant scrapie prion
protein (PrP
sc, Sc for scrapie associated/PrP
res, res for protease
resistant), a cell-surface sialoglycoprotein with a concentrated ß-
sheet conformation, that then accumulates in the diseased brain
[1]. This pathological prion protein, ‘‘PrP
d’’ where d stands for
disease-related, is regarded as the most specific element of TSEs,
also called prion diseases.
Until recently, in contrast to the diversity of experimental strains
originating from scrapie, the infectious agent responsible for the
disease in cattle was thought to be extremely uniform and stable
even following transmission to other species, and was thus
considered to belong to a single major strain of infectious agent
[2,3]. Because a relationship has been established between the
variant form of Creutzfeldt-Jakob disease in humans and the BSE
agent infecting cattle [4,5], it is crucial to recognize the different
types of infectious agents responsible for TSEs in order to secure
public health. Biochemical tests are widely used for this purpose,
particularly to distinguish scrapie from BSE cases using criteria
such as migration patterns or immunoreactivity of the prion
protein resistant to enzymatic digestion, PrP
res [6–12]. An
immunohistochemical ‘‘peptide mapping’’ method has proven
valuable for distinguishing strains in the brain and lymphoid tissue
of natural hosts [13]. These methods have been used to investigate
possible transmission of the BSE agent under natural conditions to
sheep and goats [7,8,10,12,14–16] and, intriguingly, revealed a
few cases of TSEs in sheep that showed partial similarities to
experimental ovine BSE. The prototype of such cases is the
CH1641 scrapie source, derived from a natural British scrapie-
affected Cheviot sheep, passaged several times in sheep and goats
[17] and characterized by a lower apparent molecular mass of
unglycosylated PrP
res, very close to that found in ovine BSE
[7,9,15]. Similarly, our group previously reported seven French
natural ovine ‘‘CH1641-like’’ isolates, compared with CH1641
and BSE [18,19,20]. In this study, molecular characterization
using the immunohistochemical ‘‘peptide mapping’’ method was
helpful in distinguishing these isolates—both experimental
(CH1641) and natural (O100 and O104)—from BSE [20].
Strain typing studies are usually performed after transmission of
the disease to various types of rodent, but another feature of
CH1641 is that it is not transmissible to wild-type mice [17]. The
development of transgenic mice expressing the ovine prion
protein—such as the TgOvPrP4 line that expresses the ARQ
allele—to detect and characterize the infectious agent involved in
sheep prion diseases has been decisive for these types of isolate.
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successfully shown to be transmissible in this model as reported
recently [6,18]. Following the transmission of the disease to
TgOvPrP4 mice, compared with CH1641, each of three similar
French natural TSE isolates (TR316211, O100 and O104) shared
some molecular similarities with ovine BSE, particularly the low
apparent molecular mass of unglycosylated PrP
res and weak PrPres
labeling by P4 monoclonal antibody [18].
The present paper aims to report the complete histopathological
studies of the second passage experiments with these mice. The
results of strain typing CH1641 and ‘‘CH1641-like’’ natural
scrapie in sheep in this model are compared with those of
transmission of mice scrapie strains (for which first passage data
were previously reported [21]). The results of BSE transmission
are also reported here as a control, knowing that from a
histopathological point of view it is remarkable that once
transmitted to the TgOvPrP4 mice, the BSE agent resulted in
the deposition of a pathological form of PrP as florid plaques of an
amyloid nature [22–25] whatever the original source (cattle, sheep,
cheetah or goat). The presence of this specific and rare feature,
typically found in vCJD, can therefore be used to distinguish the
BSE agent easily and accurately in this sensitive model.
To these conventional biochemical and histopathological studies
of prion strains was added the PET-blot method, which offers an
easy, quick assessment of PrP
res mapping [26]. This study proposes
an original way of learning more about the specific features of
these strains by introducing an epitopic PET-blot analysis for the
first time in such cases.
Results
Transmission of ‘‘CH1641-like’’ natural scrapie cases
The new data presented here allow us to complete the study for
which the biochemical data have previously been reported [6,18].
Table 1 summarizes the survival data and attack rates. In order to
facilitate interpretation of second passage data, the incubation
periods and attack rates of the first passage experiments previously
reported [6,21] are also given. The mean survival periods in both
firstandsecondpassageexperimentsappearverysimilar.The lesion
profile of the TR316211 isolate closely resembles the lesion profile
of the CH1641 transmission study. It was quite different from the
O100, O104 and O111 isolates, with less vacuolation. The lesion
profiles for both TR316211 and the O104 isolate, are remarkably
similar when comparing first and second passage experiments
(Fig. 1). However, because the lesion profile for TR316211 is based
on a relatively small animal population (4 and 3), the interpretation
of these data must remain limited. It was noticeable that the most
intense vacuolar lesion profile was found for the O100 isolate in
which hypothalamus, thalamus and hippocampus were particularly
triggered. It was somewhat similar to the lesion profile of O111 and
O104, especially for the second passage profile (Fig. 1).
The PrP
d brain mapping was comparable for these biochem-
ically-defined cases of ‘‘CH1641-like’’ sheep scrapie - especially in
the caudal areas - but the intensity of pathological PrP
accumulation varied between isolates. The second passage
experiments of TR316211 and O104 isolates led to notably
greater PrP
d accumulation, revealing close similarities with PrP
d
brain mapping. The O111 isolate, defined as biochemically
different from the ‘‘CH1641-like’’ sheep scrapie group, caused less
PrP
d deposition, especially in the rostral parts of the brain. The
cortex, septum, caudate-putamen, amygdala and hippocampus
gray matter sites thus remained devoid of any PrP
d accumulation
unlike the ‘‘CH1641-like’’ scrapie group. It should be noted that
the types of PrP
d deposition were similar (Fig. 2 A–F) in the
‘‘CH1641-like’’ sheep scrapie group (Fig. 2 A–F) and the O111
isolate (Fig. 2 I and J). PrP
d deposition was fine granular and
sometimes intraneuronal (Fig. 2 B, D, F, J) but never in the form of
plaques as observed with BSE (Fig. 2 L).
Table 1. Second passage transmission studies of CH1641 sheep isolate inoculated i.c. to Tg(OvPrP4) mice, compared to murine
scrapie strains (C506M3, 87V, 79A and Chandler), ‘‘CH1641-like’’ natural isolates and other natural isolates, including BSE.
Prion sources into Tg(OvPrP4)
mice
Mean survival periods at 1
st
passage Attack rate
Mean survival periods at 2
nd
passage Attack rate
Ovine scrapie strain
CH1641 245+/217 [26] 12/12 220+/231 12/12
Murine scrapie strains
C506M3 350 [21] 4/8 333+/226 12/12
Chandler 450 [21] 11/21 396+/2100 9/11
79A 540 [21] 6/15 342+/220 12/12
87V 460 [21] 9/16 258+/244 8/10
‘‘CH1641-like’’ natural ovine isolates
TR316211 235+/226 [26] 8/9 221+/231 8/11
O104 248+/250 [26] 10/10 238+/229 13/13
O100 364+/261 [26] 12/12 Not available
Other natural isolates
O111 296+/220 [26] 10/11 399+/2124 8/10
Cattle BSE 421+/248 10/10 354+/248 10/10
Incubation periods are expressed in days as the mean +/2 standard error (SE) of the mean. The incubation periods of first passage experiments already reported
elsewhere (data from [6,18,21]) are recalled in order to facilitate interpretation of the second passage data. In the case of murine scrapie strain in accordance with [21],
only approximations of mean incubation periods in days are reported. Attack rates are given to indicate transmission efficacy (number of PrPsc(IHC)/PrPres(WB) positive
mice/total number of inoculated mice). Compared to first passage experiment, the unexpected prolonged survival of ovine scrapie O111 with large SE may result from
the PrPc expression level in this mouse model as described in atypical scrapie transmission studies published previously [33].
doi:10.1371/journal.pone.0022105.t001
PrPres of Various Lengths Detected In Situ
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adapted strains
Table 1 and Figures 3 and 4 give a detailed comparison of BSE
and scrapie murine-adapted strains (C506M3, Chandler, 79A and
87V strains) transmitted in a second passage experiment with
TgOvPrP4 mice. Table 1 reports the incubation periods and
attack rates observed for each murine scrapie strain and reveals a
noticeable decrease compared to first passage experiments already
published and reviewed in Table 1 [21]. The smallest decrease was
observed for the C506M3 and Chandler strains, whereas for the
79A and 87V strains, the mean incubation periods appeared to be
drastically shorter than the first passage data. This resulted in the
87V strain becoming the fastest of all the strains (258 days post
inoculation +/244). The range of survival periods differed from
the ‘‘CH1641-like’’ group. The histopathological strain charac-
teristics summarized in Figure 3 confirmed the possibility of
distinguishing the different strains on the basis of vacuolation and
accumulation of PrP
d within the brain of each mouse analyzed.
The C506M3 and Chandler strains caused the most severe
vacuolar lesions, revealed by their lesion profiles (n=6 and n=5
respectively) (Fig. 3). The lesion profiles differed from each other
and from those in the ‘‘CH1641–like’’ group. All these vacuolar
lesions were associated with a different type of PrP
d deposition
(Fig. 4 A, E, F, H), which in this case was a synaptic-like fine
granular deposition (Fig. 4 C), often within neuronal cytoplasm
(Fig. 4 C, G, H). Apart from these granular types of PrP
d
deposition, PrP
d plaques were also seen (Fig. 2 K, L, and Fig. 4 A,
B, D). Some were amyloid plaques, revealed by birefringence
observed under polarized light after Congo red staining (Fig. 2 K).
These amyloid plaques were observed only for the C506M3,
Figure 1. Lesion profiles and PrP
d mapping (schematic representation of PrP
d distribution in violet within 4 brain levels analyzed)
observed in the brain of Tg(OvPrP4) mice (n=3 to 7) infected with either CH1641, ‘‘CH1641-like’’ French scrapie isolates on the first
or second passage (TR316211, O104, CH1641) or an isolate different from CH1641 (O111). 1. dorsal medulla nuclei, 2. cerebellar cortex, 3.
superior colliculus, 4. hypothalamus, 5. central thalamus, 6. hippocampus, 7. lateral septal nuclei, 8. cerebral cortex at the level of thalamus, 9. cerebral
cortex at the level of septal nuclei.
doi:10.1371/journal.pone.0022105.g001
PrPres of Various Lengths Detected In Situ
PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e22105Chandler and BSE strains (i.e. within the subcallosum region, the
cortex or the thalamus Fig. 2 K, L and Fig. 4 A, B, D). As already
reported in the BSE transmission study, PrP
d plaques were
surrounded by a regular ring of vacuoles which, in this model,
define the specific BSE histopathological attribute of florid plaques
(Fig. 4 K, J). The amyloid nature of PrP
d deposition detected in the
first passage experiment for 79A was no longer detected in these
second passage experiments. The most remarkable observation,
however, was the absence of PrP
d amyloid plaques as the main
type of deposition for the 87V strain.
PrP
res brain mapping using a differential PET-Blot analysis
In an attempt to clarify the characteristics of this specific group of
‘‘CH1641-like’’ sheep scrapie isolates from a histopathological point
of view, an initial set of experiments was performed using a
differential PET-blot approach. Interestingly, by using two different
monoclonal antibodies recognizing two different epitopes of the
prion protein, it was possible to reproduce a distinction that had
been previously observed biochemically between the ‘‘CH1641-
like’’ sheep scrapie and another sheep isolate (O111) or mice-
adapted scrapie strains derived from wild-type mice. Figure 5
illustratesourcomparisonofP4mAband SAF84mAblabeling with
the example of second passage experiments with positively labeled
C506M3andBSEcomparedto87V and TR316211unstainedwith
P4 mAb. In an additional comparison to negative controls such as a
non infected TgOvPrP4 mouse or a PrP KO mouse, (Fig. 5 A), the
use of P4 mAb did not detect any PrP
res in 87V-infected transgenic
mice nor in CH1641-, TR316211-, O104- or O100-infected mice
(Fig. 5B). However, some mice from the O100 experiment
contained PrP
res molecules, detected using P4. This result implies
individual variations within the experimental group. Interestingly,
inthe groupofmicepositivelylabeledusingtheP4antibody,suchas
BSE, C506M3 or 79A, the presence of PrP
res was revealed by P4
mAb to a much lesser degree than by SAF84 mAb (Fig. 5).
Discussion
In previous publications on CH1641 scrapie source transmis-
sion studies, only biochemical data and no histopathological data
were provided. In these studies, CH1641 transmission data were
analyzed in comparison to the natural ‘‘CH1641-like’’ group
(TR316211, O100 and O104) and not the ‘‘CH1641-like’’ isolate
(O111), in addition to classical murine scrapie strains and BSE
strains (defined according to their origin and biochemical criteria)
[6,18]. Importantly, these biochemical criteria implied that the
87V scrapie strain and BSE shared a low apparent molecular mass
of unglycosylated PrPres which did not react very much to the P4
antibody and which, as far as PrPres cleavage is concerned,
appeared comparable to the situation in some (O100 and O104)
or all (TR316211 and CH1641) of the TgOvPrP4 mice infected
with ‘‘CH1641-like’’ sheep TSE samples. In contrast, TgOvPrP4
mice infected with the C506M3, Chandler or 79A scrapie strains
had higher apparent molecular masses of unglycosylated PrPres
combined with intense PrPres labeling by P4 antibody. In the
present histopathological study, the vacuolar lesion profiles and
PrP
d brain mapping data for the natural ‘‘CH1641-like’’ group
showed more similarities than divergences, which may be
attributed at least in part to the intensity of PrP
d accumulation,
as suggested by the comparative data between 1
st and 2
nd passage
experiments with TR316211 and O104 isolates. Nonetheless, the
Figure 2. Illustrations of the main type of PrPd deposition as revealed by IHC using SAF84 mAb detected in the brain of TgOvPrP4
mice infected with either ‘‘CH1641-like’’ French scrapie isolates (TR316211(A, B), O104 (C, D) , O100 (E, F)), CH1641 sheep scrapie
(G, H), or other natural isolates (sheep scrapie O111 (I, J) and cattle BSE (K, L)). The main type of PrP
d deposition was granular (A–H), and
within the cytoplasm of neuronal cell bodies ((B, D, F, H, J), except for the BSE strain for which typical deposition as florid plaques was systematically
and predominantly observed (K, L). The amyloid nature of these florid plaques was revealed by examining its birefringence property under polarized
light on a section stained with Congo red (K).
doi:10.1371/journal.pone.0022105.g002
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similar to each other but clearly different from the O104 and
O100 group. It is therefore possible to group strains in accordance
with the biochemical study grouping [6,18]. However, these results
are not easy to interpret, especially because there were too few
mice available to establish the TR316211 lesion profile.
The data on the BSE and scrapie murine-adapted strains
(C506M3, Chandler, 79A and 87V strains) transmitted in a second
passage experiment to TgOvPrP4 mice showed clear differences
between strains in terms of survival periods, lesion profiles, PrP
d
brain mappings and PrP
d deposition type. Ongoing third-passage
experiments should provide some explanations for some of the
unexpected evolutions in the histopathological data recorded,
especially for the 79A and 87V strains. While waiting for the
results of this third-passage experimental study, we have
considered analyzing the present data further by developing a
differential PET-blot analysis. In an attempt to find ways of
unifying the biochemical and histopathological data on strain
typing, we decided to pursue the histopathological analysis of the
brains of TgOvPrP4 mice infected with these scrapie sources. An
initial set of experimental data underwent an epitopic PET blot
analysis, developed on the basis of the comparative use of SAF84
and P4 mAbs that recognized two different epitopes of the prion
protein. Initial findings showed that it is possible to reproduce a
classification based on P4 reactivity. The BSE, C506M3, Chandler
and 79A groups showed P4-detected PrP
res molecules, unlike the
87V, CH1641 and TR316211 group. Some mice from the O100
experiment had PrP
res molecules detected using P4, implying
individual variations within the experimental group, an implica-
tion also suggested by the wide variations in lesion profiles
consistent with biochemical analyses [18]. It should be noted that
for all mice in this group positively labeled by P4, the PrP
res
labeling was less intense than that detected using SAF84. All the
regions that accumulated PrP
res detected using P4 were system-
atically SAF84–positive too, whereas not all the regions that
accumulated PrP
res detected using SAF84 were positively labeled
using P4 mAb. This may indicate that only specific brain regions
or cell types may express the PrP
res molecules detected using P4,
whereas more brain regions and cell types express PrP
res molecules
detectable only with SAF84. We cannot exclude the possibility that
the P4 antibody may be less sensitive. However, this observation
was reproducible using another prion antibody recognizing the
same epitopic region recognized by P4 (data not shown). To better
characterize the type of cells concerned, a detailed differential
immunohistochemical analysis of these specific regions will be
necessary. This would actually be a suitable way of apprehending
the biological origin of these different forms of PrP
d detected in situ.
As observed in the sheep species, these different kinds of
immunoreactivity probably reveal different levels of naturally-
occurring enzymatic cleavage of the PrP
d, which may depend on
the strain of agent and the type of brain cell considered [27].
However, this approach would probably raise a new set of issues
because the epitopic PET-Blot focuses on the results of the
controlled enzymatic digestion of PrPd molecules using PK in situ,
Figure 3. Lesion profiles and PrP
d mapping (schematic representation of PrP
d distribution in violet within 4 brain levels analyzed)
observed in the brain of Tg(OvPrP4) mice (n=4 to 6) infected with either C506M3, Chandler, 79A, 87V or BSE strains on second
passage. Red dots symbolize amyloid florid plaques typical of the BSE infectious agent detected in this transgenic mouse model.
doi:10.1371/journal.pone.0022105.g003
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investigate the ‘‘natural truncation’’ of PrPd molecules that exists
at cellular level. An epitopic PET Blot analysis is an original way of
obtaining an approximation in situ of the length of the PrPres
molecules accumulated in the brain of mice experimentally
infected with different prion strains. The advantage is that this
method can be used to characterize a variety of PrPres
molecules—similar to detection by WB—directly in situ within
the brain depending on the prion strains. Unfortunately, we
cannot at this stage identify, of all the PrP
res molecules detected in
situ using SAF84, which ones may be related to the additional
PrP
res fragment (named PrP
res #2) described recently by our
group [6]. This C-terminally cleaved PrP
res product detected using
SAF84 mAb specifically in the ‘‘CH1641-like’’ isolates compared
to 79A, Chandler and C506M3 strains and transmitted to
TgOvPrP4 mice, helps differentiate these prion groups.
Many more experiments related to these biochemically-defined
groups, together with the use of several other possible anti-prion
antibodies, are already planned. Importantly, this complementary
histopathological tool already provides data showing strain
properties concordant with the biochemical characterization of
this particular group of prion agents.
Materials and Methods
Ethics statement
All procedures were carried out in compliance with the
guidelines laid down by the Regional (CREEA no. 98) and
French (Decree 87–848) Ethical Committees and European
Community Directive 86/609/EEC. Animal experiments were
performed in the ANSES animal facilities which have the relevant
approval to carry out animal work (A 69 387 0801) by licensed
people working in the animal experiment unit (license numbers
AB: 69 387 531, LL: 69 387 191).
Scrapie agents
The different scrapie sources used are presented in Table 1.
Some of them are derived from mouse-adapted strains (79A, 87V,
C506M3 and Chandler) transmitted in a first passage experiment
by the i.c. route to TgOvPrP4 mice, or sheep-passaged isolates
(CH1641), as well as four natural French TSE isolates, three
‘‘CH1641-like’’ isolates (TR316211, O100 and O104) and one not
CH1641-like (O111). Transmission studies and the molecular
analyses of CH1641 and of other natural ‘‘CH1641-like’’ isolates
transmitted to TgOvPrP4 ovine transgenic mice have already been
described [6,18,28].
Experimental design
Groups of 12 female TgOvPrP4 mice [29], 4 to 6 weeks old,
were challenged intracranially with 20 ml of 10% (1
st passage) or
1% (2
nd passage) (wt/vol) brain homogenates in 5% glucose in
Figure 4. Illustrations of the main type of PrPd deposition as
revealed by IHC using SAF84 mAb detected in the brain of
TgOvPrP4 mice infected with either C506M3 (A, B), Chandler
(C, D), 79A (E, F), or 87V (G, H) scrapie strains. PrPd was detected
as amyloid plaques (A, B, D), fine granular linear and intraneuronal
deposits (C, F, G, H). In the case of the 79A strain granular PrP
d
deposition was seen within the white matter (E).
doi:10.1371/journal.pone.0022105.g004
Figure 5. Epitopic PET-Blot analysis. Illustrations of comparative
PrP
res detection with P4 and SAF84 mAb using a PET-blot analysis. A.
The brains of a non inoculated TgOvPrP4 mouse and a PrP KO mouse
were used as negative controls and showed no PrP
res deposition. B. The
brains of a TgOvPrP4 mouse inoculated with C506M3, 87V or TR316211
or with BSE strains by the i.c. route. PrP
res, observable as dark blue
deposits on these membranes, was detectable in each case using SAF84
but not using P4 mAb. PrP
res revealed by this antibody was present in
the C506M3 and BSE experiment and not in the second passage
experiment of 87V or the TR316211 isolate. In C506M3- just as in BSE-
infected brains, P4-labeled PrP
res accumulated in less specific brain
areas and in smaller quantities than shorter PrP
res forms detected by the
SAF84 prion antibody.
doi:10.1371/journal.pone.0022105.g005
PrPres of Various Lengths Detected In Situ
PLoS ONE | www.plosone.org 6 July 2011 | Volume 6 | Issue 7 | e22105distilled water. This transgenic mouse model (TgOvPrP4)
overexpresses in the brain, between 1.5 and 6 times the levels of
the PrPARQ ovine prion protein under the control of the neuron-
specific enolase promoter [29]. A source of BSE agent was also
transmitted to TgOvPrP4 mice, used as a control group for the
CH1641 group. The mice were euthanized at the terminal stage of
disease development.
Histological examinations
On death, the mouse brains were removed and processed either
for biochemical (frozen at 220uC) or histochemical (fixed in 4%
buffered paraformaldehyde) detection of PrP
d following procedures
published indetailelsewhere[21,30]. Amyloiddeposits and vacuolar
lesions were examined on brain sectionsstained with Congo red [22]
and hematoxylin-eosin (HE) respectively. Lesion profiles were
established according to Fraser’s lesion profile [31] by quantification
using a computer-assisted method (Morpho Expert software,
Explora Nova, La Rochelle, France) [32]. Brain slices were
immunostained for PrP
d as previously described with pre-treatments
designed to enhance PrP
d detection using SAF84 (SPI Bio, Massy,
France) or P4 monoclonal antibody (R-Biopharm, St Didier au
Mont d’Or, France) which maps to the regions 167RPVDQY172 and
93WGQGGSH99 of ovine PrP respectively [20,21]. A peroxidase-
labeled avidin-biotin complex (Vectastain Elite ABC, Vector
Laboratories, Burlingame, CA) was used to amplify the signal.
To visualize in situ the resistant form of abnormal PrP (PrP
res)
after digestion with a high concentration of proteinase K (PK), the
PET-blot method was used as previously described [26]. Briefly, 5-
mm-thick paraffin sections were collected onto 0.45 mm pore
nitrocellulose membranes (Biorad, Marne la Coquette, France).
The membranes were dewaxed and dried at room temperature
(RT). After wetting with TBST (10 mM Tris HCl, pH 7.8;
100 mM NaCl; 0.05% Tween 20), enzymatic digestion was
performed using 250 mg/ml PK (Roche-Boehringer, Meylan,
France) in a buffer made of 10 mM Tris HCl, pH 7.8, 100 mM
NaCl, 0.1% Brij 35, for 8 hours at 55uC. Membranes were treated
with guanidine isothiocyanate (3 M, 10 min), then thoroughly
washed in TBST. Immunodetection was performed after pre-
incubation in a blocking solution (skimmed milk diluted at 0.2% in
TBST). The monoclonal antibody used was either SAF84 (1/
2500) or P4 (1/1000) for one night at RT. A phosphatase alkaline
coupled anti-mouse antibody (Clinisciences, Montrouge, France)
was used as the secondary antibody (1/500, 37uC, 45 min). Before
revelation, the pH was adjusted to 9 by incubating membranes in
NTM buffer (100 mM Tris-HCl, pH 9.5, 100 mM NaCl, 50 mM
MgCl2). Finally, NBT/BCIP (Clinisciences, Montrouge, France)
was used to visualize the reaction product (dark blue deposits).
PET-blot membranes were assessed using a stereo-microscope
(Olympus, Rungis, France) linked to an image analysis workstation
(Explora Nova, La Rochelle, France).
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